Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor Outcome

scientific article published on 01 July 2011

Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor Outcome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/TP.0B013E318222C9C6
P698PubMed publication ID21637139

P50authorAnthony DorlingQ37837734
Candice RoufosseQ61114342
P2093author name stringDavid Taube
Adam G McLean
Jack W Galliford
Michelle Willicombe
Anthony N Warrens
Paul Brookes
Tom D Cairns
Terry H Cook
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectantibodyQ79460
P304page(s)176-182
P577publication date2011-07-01
P1433published inTransplantationQ15730500
P1476titleAntibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome
P478volume92

Reverse relations

cites work (P2860)
Q52939658A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
Q44075598Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes
Q38544529Advances in pharmacotherapy to treat kidney transplant rejection
Q86254890Alemtuzumab induction and antibody-mediated rejection in kidney transplantation
Q43681319Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients
Q37698860Antibody-Mediated Rejection: A Review
Q38206175Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options
Q90696052Automated detection algorithm for C4d immunostaining showed comparable diagnostic performance to pathologists in renal allograft biopsy
Q47313617Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients
Q38079301Clinical relevance of antibody development in renal transplantation
Q39025865Crosstalk Between T and B Cells in the Germinal Center After Transplantation.
Q26998713Detection and clinical relevance of donor specific HLA antibodies: a matter of debate
Q34841849Diagnosis and management of antibody-mediated rejection: current status and novel approaches
Q47286616Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection.
Q38022711Identification and therapeutic management of highly sensitized patients undergoing renal transplantation.
Q41782407Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment.
Q38212985Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation
Q52793674Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings.
Q27015093Regulatory B cells: an exciting target for future therapeutics in transplantation
Q38746225Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients
Q92381767Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study
Q33891696The role of B cells in solid organ transplantation.

Search more.